320 ILCS 50/25
Study of catastrophic pharmaceutical assistance coverage
Illinois · Illinois Compiled Statutes 320 ILCS 50 — Senior Pharmaceutical Assistance Act. · Status: effective
Cite this
- Citation
- 320 ILCS 50/25, Study of catastrophic pharmaceutical assistance coverage, Illinois, version 1 as recorded 2026-08-14, yourstate.us, https://yourstate.us/provision/1290932
- Permanent ID
ys:prov:1290932@1- SHA-256
61ea2727a7b0cded57d4932ae3915fb713ce661ee13454e6c7686db70a2d8f4e
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
Study of catastrophic pharmaceutical assistance coverage.
(a) The Illinois Comprehensive Health Insurance Board shall study a catastrophic pharmaceutical assistance coverage option. The Board may contract with a private entity for the completion of all or part of the study. Specifically, the study shall:
(1) Assess the need for a catastrophic pharmaceutical assistance coverage option, including information on the number of individuals in need of such a benefit.
(2) Estimate the cost of providing a catastrophic pharmaceutical assistance coverage option through the Illinois Comprehensive Health Insurance Plan or another public or private entity.
(3) Recommend ways to create a catastrophic pharmaceutical assistance coverage option.
(b) The Board may accept donations, in trust, from any legal source, public or private, for deposit into a specially created trust account and for expenditure, without the necessity of being appropriated, solely for the purpose of conducting all or part of the study.
(c) The Board may enter into intergovernmental agreements with other State agencies for the purpose of conducting all or part of the study.
(d) The Board shall issue a report with recommendations to the Governor and the General Assembly by January 1, 2003. (Source: P.A. 92-594, eff. 6-27-02.)